glp-1 cardiovascular outcomes trial results august 2025 Effects and Tolerability of Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients Cardiovascular Risks after GLP-1 Discontinuation

Zhang W, Joseph E, Hitchcock C, DiSilvestro RA

He Y, Guo X, Tan B, Dong X, Yang Q, Liu H, Zhang S, Chi S (2021

Current clinical practice considerations emphasize the importance of ophthalmologic screening before initiating GLP-1 therapy in patients with longstanding diabetes and implementing more gradual titration schedules in those with known retinal disease to minimize the risk of early worsening

Reeves, Varenicline Phase 3 Study Group, Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

With Recharge, you can say goodbye to your bed and hello to a world of possibilities

What should I expect when I get a mammogram